Project Details
Description
The funded project is intended to design and acquire phosphorodiamidate morpholino oligos ("PMOs") FROM Gene Tools, Inc that are intended to cause exon skipping in human cells such that a truncated form of gamma sarcoglycan is produced.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/14 → 9/30/15 |
Funding
- Kurt + Peter Foundation (Agmt 10/27/14)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.